All
Research
Education
Recherche
Enseignement
Business
Solutions
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
S'identifier
Institute of Cancer Sciences
Gillian Farnie has not added Biography.
If you are Gillian Farnie and would like to personalize this page please email our Author Liaison for assistance.
The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.
The Journal of biological chemistry Jan, 2004 | Pubmed ID: 14593113
Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction.
Bioorganic & medicinal chemistry letters Mar, 2005 | Pubmed ID: 15713419
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction based on an isoindolinone scaffold.
Journal of medicinal chemistry Oct, 2006 | Pubmed ID: 17034127
Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.
Journal of the National Cancer Institute Apr, 2007 | Pubmed ID: 17440163
Mammary stem cells and breast cancer--role of Notch signalling.
Stem cell reviews Jun, 2007 | Pubmed ID: 17873349
Prolactin receptor antagonism reduces the clonogenic capacity of breast cancer cells and potentiates doxorubicin and paclitaxel cytotoxicity.
Breast cancer research : BCR , 2008 | Pubmed ID: 18681966
Are stem-like cells responsible for resistance to therapy in breast cancer?
Breast disease , 2008 | Pubmed ID: 19029627
Resistance to endocrine therapy: are breast cancer stem cells the culprits?
Journal of mammary gland biology and neoplasia Mar, 2009 | Pubmed ID: 19252972
Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor.
Cancer research Jan, 2010 | Pubmed ID: 20068161
Breast cancer stem cells: something out of notching?
Cancer research Nov, 2010 | Pubmed ID: 21045140
Breast cancer stem cells and their role in resistance to endocrine therapy.
Hormones & cancer Apr, 2011 | Pubmed ID: 21761332
P-Cadherin is Co-Expressed with Cd44 and Cd49f and Mediates Stem Cell Properties in Basal-Like Breast Cancer.
Stem cells (Dayton, Ohio) Mar, 2012 | Pubmed ID: 22389315
A detailed mammosphere assay protocol for the quantification of breast stem cell activity.
Journal of mammary gland biology and neoplasia Jun, 2012 | Pubmed ID: 22665270
Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms.
Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2013 | Pubmed ID: 23149820
Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
PloS one , 2013 | Pubmed ID: 23457626
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.
Breast cancer research : BCR , 2013 | Pubmed ID: 24041156
Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS).
Cell cycle (Georgetown, Tex.) , 2014 | Pubmed ID: 24247151
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
Oncotarget Feb, 2014 | Pubmed ID: 24583601
Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy.
Stem cells (Dayton, Ohio) Feb, 2015 | Pubmed ID: 25187396
Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
Cell reports Sep, 2015 | Pubmed ID: 26387946
High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Oncotarget Oct, 2015 | Pubmed ID: 26421710
Three-dimensional modelling identifies novel genetic dependencies associated with breast cancer progression in the isogenic MCF10 model.
The Journal of pathology Nov, 2016 | Pubmed ID: 27512948
Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.
Journal of mammary gland biology and neoplasia Dec, 2016 | Pubmed ID: 27680982
Erratum to: Patient-Derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis.
Journal of mammary gland biology and neoplasia Dec, 2016 | Pubmed ID: 27815673
University of Manchester
Eamonn Morrison1,2,
Patty Wai1,2,
Andri Leonidou1,2,
Philip Bland1,2,
Saira Khalique1,2,
Gillian Farnie3,
Frances Daley1,
Barrie Peck1,2,
Rachael Natrajan1,2
1The Breast Cancer Now Toby Robins Research Centre, Division of Breast Cancer, The Institute of Cancer Research,
2Division of Molecular Pathology, The Institute of Cancer Research,
3Institute of Cancer Sciences, University of Manchester
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Tous droits réservés.
Nous utilisons des cookies afin d'améliorer votre expérience sur notre site web.
En continuant à utiliser notre site ou en cliquant sur le bouton ''continuer'', vous acceptez l'utilisation de cookies.
Apprendre encore plus